GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Recursion Pharmaceuticals
Recursion Pharmaceuticals uses artificial intelligence to accelerate drug discovery. Its stock price represents a venture capital bet that its technology platform will radically transform the pharmaceutical industry. The chart reflects the excitement and risks associated with AI in biotech.
Share prices of companies in the market segment - AI
Recursion is a biotech company using artificial intelligence and robotics to accelerate drug discovery. We classify it as part of the AI sector, and the chart below shows the dynamics of the entire TechBio segment, where value is determined by confidence in the technology platform.
Broad Market Index - GURU.Markets
Recursion Pharmaceuticals is a biotech company that uses artificial intelligence and robotics to accelerate drug discovery. Its innovative approach makes it a key component of the GURU.Markets index. The chart below represents the entire market. Find out how Recursion compares to it.
Change in the price of a company, segment, and market as a whole per day
RXRX - Daily change in the company's share price Recursion Pharmaceuticals
For Recursion, a biotech company at the intersection of AI, change_co is a measure of innovation volatility. Daily fluctuations reflect investor confidence in its technology platform and partnership news. This metric is a key element for analyzing high-risk tech assets on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - AI
Recursion Pharmaceuticals, Inc. is a company at the intersection of biotech and AI. This chart highlights the sector's extreme volatility. Comparison with RXRX, a company using AI for drug discovery, helps to assess it as a high-risk asset dependent on technological breakthroughs.
Daily change in the price of a broad market stock, index - GURU.Markets
Recursion is a biotech company using artificial intelligence to accelerate drug discovery. This is a cutting-edge and highly speculative field at the intersection of biotech and AI. The chart below illustrates the high volatility typical of this sector, reflecting the enormous expectations and risks.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Recursion Pharmaceuticals
Recursion is a unique biotech company that uses robotics and AI to accelerate drug discovery. Its year-over-year performance reflects investors' confidence in the potential of its platform to revolutionize pharmaceuticals.
Annual dynamics of market capitalization of the market segment - AI
Recursion Pharmaceuticals, Inc. uses artificial intelligence and robotics to accelerate drug discovery. Its technology platform is its key advantage. The chart shows how the market views its innovative yet capital-intensive approach to drug development compared to traditional biotech.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Recursion, which uses AI to discover new drugs, is a hybrid of biotech and IT. Its stock price is a speculative bet that artificial intelligence will revolutionize pharmaceuticals. The chart isn't tied to economics, but rather reflects investors' faith in one of the most ambitious ideas at the intersection of two industries.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Recursion Pharmaceuticals
Recursion, a biotech company using AI and automation to accelerate drug discovery, shows monthly fluctuations not so much in specific drugs as in the progress of its platform and partnerships with major pharmaceutical companies.
Monthly dynamics of market capitalization of the market segment - AI
The use of artificial intelligence in drug discovery is revolutionizing the pharmaceutical industry. The dynamics of this young sector, reflected in the chart, reveal enormous expectations and high volatility. Companies like Recursion, which are changing the R&D paradigm, are at the forefront of this movement.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Recursion Pharmaceuticals uses AI to discover new drugs, betting on the intersection of biotech and technology. The company's shares are highly volatile, reflecting both the hype around AI and the risks inherent in biotech development.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Recursion Pharmaceuticals
Recursion Pharmaceuticals uses artificial intelligence and robotics to accelerate drug discovery. Its weekly stock price has been highly volatile, reflecting both the general excitement around AI in biotech and specific news about progress in its numerous development programs.
Weekly dynamics of market capitalization of the market segment - AI
Recursion, which uses AI for drug development, operates at the intersection of two hyped sectors—biotech and AI. Its performance is highly volatile and often outperforms traditional pharma. The chart clearly shows how the market is pricing in high expectations for its technology platform, which sets it apart from its competitors.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Recursion uses AI to accelerate drug discovery, one of the most hyped topics in biotech. The company's shares are highly volatile, reflecting investors' faith in the AI revolution in medicine. The chart below will show this speculative dynamic.
Market capitalization of the company, segment and market as a whole
RXRX - Market capitalization of the company Recursion Pharmaceuticals
Recursion Pharmaceuticals' market capitalization reflects investors' bets on the use of artificial intelligence to accelerate drug discovery. Its volatile price reflects the high interest in its technology platform, as well as the risks associated with proving its effectiveness through lengthy and expensive clinical trials.
RXRX - Share of the company's market capitalization Recursion Pharmaceuticals within the market segment - AI
Recursion Pharmaceuticals uses artificial intelligence and robotics to accelerate drug discovery. Its market share reflects its status as a leader in the "TechBio" space. Its market cap reflects its bet that its platform will transform the pharmaceutical industry.
Market capitalization of the market segment - AI
Here's a chart showing the market capitalization of the AI-driven biotech sector. Recursion Pharmaceuticals is a pioneer, using artificial intelligence to accelerate drug discovery. The explosive growth of this market you see reflects the hope that AI will revolutionize pharmaceuticals, and Recursion is at the forefront of this movement.
Market capitalization of all companies included in a broad market index - GURU.Markets
Recursion Pharmaceuticals uses AI and robotics to accelerate drug discovery. Its market cap is a bet that AI will revolutionize pharmaceuticals. The chart below shows the growing economic importance of the AI biotech sector, which is transforming research.
Book value capitalization of the company, segment and market as a whole
RXRX - Book value capitalization of the company Recursion Pharmaceuticals
Recursion Pharmaceuticals' book value is derived from its unique platform, which leverages robotics and artificial intelligence to accelerate drug discovery. The company's foundation is a fusion of biology and IT. The chart shows how the company is investing raised capital into expanding its operating system to "industrialize" the R&D process.
RXRX - Share of the company's book capitalization Recursion Pharmaceuticals within the market segment - AI
Recursion Pharmaceuticals uses AI for drug discovery. The chart shows its share of real assets. These are its unique automated labs, where robots conduct millions of experiments, generating massive data sets for training AI models.
Market segment balance sheet capitalization - AI
Recursion Pharmaceuticals uses AI for drug discovery, making its model unique. It's more capital-intensive than pure software companies, requiring automated labs, but lighter than traditional pharmaceutical companies. Within the industry, it's an example of a hybrid model, where IT infrastructure is just as important as wet labs.
Book value of all companies included in the broad market index - GURU.Markets
Recursion Pharmaceuticals' assets aren't test tubes, but robotic labs and AI that analyze cellular images to discover new drugs. The company's balance sheet reflects the value of this unique "discovery factory." The chart shows how much capital has been invested in a technological approach designed to radically accelerate drug development.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Recursion Pharmaceuticals
Recursion Pharmaceuticals uses artificial intelligence to accelerate drug discovery. Its book value is primarily cash and equipment, but its market capitalization is the valuation of its revolutionary technology platform. Investors are paying for the potential to change the very paradigm of pharmaceutical R&D.
Market to book capitalization ratio in a market segment - AI
Recursion Pharmaceuticals uses AI to discover new drugs. It's a synergy between biotech and technology. This chart shows the vast gap between the market valuation based on its platform's potential and the value of its physical assets. Investors are betting that its approach will dramatically accelerate drug development.
Market to book capitalization ratio for the market as a whole
Recursion Pharmaceuticals uses artificial intelligence to accelerate drug discovery. Its value lies in its unique technology platform, not its lab equipment. The chart clearly demonstrates the enormous premium the market is paying for the potential of AI technologies to revolutionize pharmaceuticals.
Debts of the company, segment and market as a whole
RXRX - Company debts Recursion Pharmaceuticals
Recursion Pharmaceuticals uses artificial intelligence to accelerate drug discovery. This innovative approach requires significant investments in computing power, automated labs, and data analysis. Debt capital helps the company scale its unique platform and expand its portfolio of research programs.
Market segment debts - AI
Recursion Pharmaceuticals uses artificial intelligence to accelerate drug discovery. It's an innovative but very expensive business model. Its debt policy may be unusual. This chart shows how the company finances its unique R&D platform and how its financial strategy differs from traditional biotech companies.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Recursion Pharmaceuticals
Recursion Pharmaceuticals uses artificial intelligence and robotic automation to accelerate drug discovery. This chart shows the financial position of the biotech company. Its lack of debt and reliance on massive equity capital are essential for funding its unique and expensive research platform.
Market segment debt to market segment book capitalization - AI
Recursion Pharmaceuticals uses artificial intelligence to accelerate drug discovery. This chart reflects debt trends in the innovative biotech and AI sector. It allows one to assess how the company finances its unique technological approach compared to more traditional pharmaceutical companies and other AI startups.
Debt to book value of all companies in the market
Recursion Pharmaceuticals uses AI for drug discovery, requiring venture capital. The chart reflects debt trends across the economy. It highlights the contrast: while the market operates according to the laws of credit cycles, Recursion and companies like it operate according to the laws of scientific breakthroughs and funding rounds.
P/E of the company, segment and market as a whole
P/E - Recursion Pharmaceuticals
This chart for Recursion Pharmaceuticals, which uses AI for drug discovery, is a clear bet on a technological revolution in pharma. Its potential profit valuation is extremely high, as investors are buying the platform, not the drugs. The momentum reflects the belief that their data-driven approach will dramatically speed up and reduce the cost of drug development.
P/E of the market segment - AI
This chart reflects the collective expectations of the entire pharmaceutical AI industry, of which Recursion is a pioneer. Sky-high average valuations are the norm for this sector. For investors, this benchmark raises the question of whether Recursion's valuation matches or exceeds the general belief that AI will transform drug discovery.
P/E of the market as a whole
Recursion Pharmaceuticals uses artificial intelligence to accelerate the drug discovery process. This revolutionary approach attracts investors who believe in the synergy between technology and biology. This chart shows how much the market is generally willing to pay for such futuristic ideas. During periods of hype, Recursion's valuation can soar, but fall when the market cools.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Recursion Pharmaceuticals
Recursion Pharmaceuticals is using artificial intelligence to accelerate drug discovery. It's a high-tech bet on revolutionizing pharmaceuticals. This chart shows how analysts assess the company's platform's potential to generate successful drug candidates and partner with major pharma companies in the future.
%20P%2FE%20Recursion%20Pharmaceuticals&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Recursion-Pharmaceuticals&v=1772449011741 "Chart of the company's future (projected) P/E Recursion Pharmaceuticals")
Future (projected) P/E of the market segment - AI
Recursion Pharmaceuticals uses artificial intelligence and robotics to accelerate drug discovery. Its valuation, compared to traditional pharmaceutical and biotech companies, reflects the high expectations for its technology platform. Investors are betting that its approach will fundamentally transform pharmaceutical R&D.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20AI&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-AI&v=1772449011746 "Future (projected) P/E graph of the market segment - AI")
Future (projected) P/E of the market as a whole
Recursion Pharmaceuticals uses artificial intelligence and robotics to accelerate drug discovery, betting on a revolution in pharmaceuticals. This chart shows investors' overall appetite for risk and technological innovation. Market optimism is fueling capital flows into ambitious platform companies like Recursion.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772449011752 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Recursion Pharmaceuticals
Recursion Pharmaceuticals uses artificial intelligence and robotics to accelerate drug discovery. The company's financial performance reflects its significant investment in its unique technology platform. Future results depend on this system's ability to identify new therapeutic targets and successful partnerships.
Profit of companies in the market segment - AI
Recursion Pharmaceuticals uses artificial intelligence to accelerate drug discovery, a revolutionary approach to pharmaceuticals. This chart shows the total profits of biotech companies. It helps us understand whether the innovative, AI-driven approach to R&D has begun to yield real financial benefits for the entire industry.
Overall market profit
Recursion Pharmaceuticals uses artificial intelligence and robotics to accelerate drug discovery. It's a technology platform at the intersection of biotech and AI. Its value lies in its potential to transform the pharmaceutical industry. This graph is important for the investment climate, but RXRX's success fundamentally depends on its platform's ability to discover effective drugs.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Recursion Pharmaceuticals
Recursion Pharmaceuticals uses artificial intelligence and robotics to accelerate the drug discovery process, aiming to revolutionize pharmaceutical research. The company's long-term revenue forecast reflects analysts' belief that the company's technology platform can efficiently and quickly develop new drugs.
%20profit%20of%20the%20company%20Recursion%20Pharmaceuticals&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Recursion-Pharmaceuticals&v=1772449011783 "Graph of future (projected) profit of the company Recursion Pharmaceuticals")
Future (predicted) profit of companies in the market segment - AI
Recursion Pharmaceuticals uses artificial intelligence and robotics to accelerate drug discovery. Their platform analyzes cell images to identify potential treatments. This chart shows forecasts for the AI segment in pharma, illustrating the enormous hopes investors have for the application of AI to revolutionize drug development.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20AI&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-AI&v=1772449011798 "Graph of future (predicted) profits of companies in a market segment - AI")
Future (predicted) profit of the market as a whole
Recursion Pharmaceuticals uses artificial intelligence and robotics to accelerate drug discovery. This projected profitability profile influences investor willingness to fund breakthrough technologies. During periods of economic optimism, capital is more readily invested in capital-intensive projects with long-term payback, such as Recursion's innovative platform.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772449011804 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Recursion Pharmaceuticals
Recursion Pharmaceuticals uses artificial intelligence to accelerate drug discovery. This chart shows how highly investors rate its approach, despite its modest current revenue. It's a bet that its platform will fundamentally change the pharmaceutical industry.
P/S market segment - AI
Recursion Pharmaceuticals uses artificial intelligence and robotics to accelerate drug discovery. This chart shows the average valuation in the AI and biotech sector. It reflects the premium investors are willing to pay for Recursion's revolutionary approach, which could radically change the drug development process and reduce time and costs.
P/S of the market as a whole
Recursion Pharmaceuticals uses artificial intelligence and robotics to accelerate drug discovery. It's a technology platform applied in biotech. Future revenue depends on the success of this model. This chart serves as a contrast, showing the difference between the valuation of a breakthrough technology and the average valuation of revenue already generated in the market.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Recursion Pharmaceuticals
Recursion Pharmaceuticals uses artificial intelligence to accelerate drug discovery. The company's valuation is based on expectations for its technology platform. This chart illustrates investors' belief that Recursion's AI approach will enable faster and cheaper drug discovery, leading to massive future revenues.
%20P%2FS%20Recursion%20Pharmaceuticals&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Recursion-Pharmaceuticals&v=1772449011828 "The graph of the company's future (projected) P/S Recursion Pharmaceuticals")
Future (projected) P/S of the market segment - AI
Recursion Pharmaceuticals uses artificial intelligence and robotics to accelerate drug discovery. Its platform analyzes cellular images to identify potential treatments. This chart shows how investors view the potential of this technology platform for drug discovery compared to other biotech companies.
%20P%2FS%20market%20segment%20graph%20-%20AI&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-AI&v=1772449011834 "Future (projected) P/S market segment graph - AI")
Future (projected) P/S of the market as a whole
This indicator demonstrates the market's faith in the power of artificial intelligence. For Recursion Pharmaceuticals, which uses AI and robotics to discover new drugs, it's a sign of investor readiness for the technological revolution in pharmaceuticals. Market optimism fuels the belief that this approach can dramatically speed up and reduce the cost of drug development.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772449011840 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Recursion Pharmaceuticals
Recursion Pharmaceuticals is a biotech company using artificial intelligence and automated laboratories to accelerate drug discovery. This chart reflects revenue from collaborations with major pharmaceutical companies. Its growth will reflect the successful application of the platform for identifying new therapeutic targets and drug candidates.
Sales of companies in the market segment - AI
Recursion Pharmaceuticals uses artificial intelligence and robotics to accelerate drug discovery. This chart illustrates the growth of the AI-driven biotech sector. Recursion's platform is capable of analyzing cellular images on a massive scale, enabling the discovery of new therapeutic targets and revolutionizing pharmaceuticals.
Overall market sales
Recursion Pharmaceuticals uses artificial intelligence to accelerate drug discovery. The company's growth depends on investment in technology and science. Overall economic activity, shown in this chart, influences the willingness of venture capitalists and large pharmaceutical companies to invest in cutting-edge platforms like the one Recursion is developing.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Recursion Pharmaceuticals
Recursion Pharmaceuticals uses artificial intelligence and robotics to accelerate drug discovery. The company generates massive biological datasets to search for new treatments. This graph reflects analysts' bet that Recursion's technology platform will significantly improve R&D efficiency and lead to the development of successful drugs.
%20sales%20of%20the%20company%20Recursion%20Pharmaceuticals&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Recursion-Pharmaceuticals&v=1772449011868 "Schedule of future (projected) sales of the company Recursion Pharmaceuticals")
Future (projected) sales of companies in the market segment - AI
Recursion Pharmaceuticals uses artificial intelligence and robotics to accelerate drug discovery. This forecast reflects expectations for the entire AI biotech sector. It highlights the enormous potential analysts see in using these technologies to revolutionize R&D, which is at the core of Recursion's business model.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20AI&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-AI&v=1772449011872 "Schedule of future (projected) sales of companies in the market segment - AI")
Future (projected) sales of the market as a whole
Recursion Pharmaceuticals uses artificial intelligence and robotics to accelerate drug discovery. The company's success depends on the effectiveness of its platform and its ability to identify new therapeutic targets. This graph, reflecting the state of the economy, influences venture capital flows into high-tech sectors, which Recursion depends on to fund its ambitious projects.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772449011876 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Recursion Pharmaceuticals
Recursion Pharmaceuticals uses artificial intelligence to accelerate drug discovery. This chart illustrates the scale of investment in this cutting-edge platform. The huge negative values represent the cost of creating a "map" of human biology, which could be recouped many times over in the future by rapidly discovering effective therapies.
Market segment marginality - AI
Recursion Pharmaceuticals uses artificial intelligence and robotics to accelerate drug discovery. It is a technology platform used in biotechnology. The profitability of this model depends on the success of drug discovery. This chart reflects its unique operational structure compared to traditional pharmaceutical companies.
Market marginality as a whole
Recursion Pharmaceuticals uses artificial intelligence and robotics to accelerate drug discovery. This overall economic profitability chart is of secondary importance to the company. The company's potential lies in its platform, which has the potential to fundamentally change the pharmaceutical industry. Its success depends on technological breakthroughs, not market cycles.
Employees in the company, segment and market as a whole
Number of employees in the company Recursion Pharmaceuticals
Recursion Pharmaceuticals uses artificial intelligence and robotics to accelerate drug discovery. This chart shows a unique combination of biologists, chemists, and data scientists. The growth reflects the scaling of their technology platform and the expansion of their research program portfolio.
Share of the company's employees Recursion Pharmaceuticals within the market segment - AI
Recursion Pharmaceuticals uses artificial intelligence and robotics to accelerate drug discovery. This chart shows the company's talent pool at the intersection of biology, chemistry, and data science. It reflects its status as a pioneer in digital biotechnology and the concentration of talent needed to revolutionize the pharmaceutical industry.
Number of employees in the market segment - AI
Recursion Pharmaceuticals, Inc. uses artificial intelligence and automated biological experiments to discover new drugs faster. Their platform analyzes cellular images to identify potential treatments. This chart reflects the growth of employment at the intersection of AI and biotechnology, demonstrating how digitalization and machine learning are revolutionizing the drug development process.
Number of employees in the market as a whole
Recursion Pharmaceuticals uses artificial intelligence and robotics to accelerate drug discovery. This synergy between biotechnology and IT is transforming the pharmaceutical industry. The company creates unique cross-disciplinary jobs that require competencies in both biology and data analysis, building a talent pool for the economy of the future.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Recursion Pharmaceuticals (RXRX)
Recursion Pharmaceuticals uses artificial intelligence to accelerate drug discovery. This chart is a prime example of the AI biotech's valuation. The astronomical market cap per employee indicates the market sees enormous potential in their platform, which can radically reduce the time and cost of drug development.
%20of%20the%20company%20Recursion%20Pharmaceuticals%20(RXRX)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Recursion-Pharmaceuticals-RXRX&v=1772449011924 "Chart of market capitalization per employee (in thousands of dollars) of the company Recursion Pharmaceuticals (RXRX)")
Market capitalization per employee (in thousands of dollars) in the market segment - AI
Recursion Pharmaceuticals (RXRX) is a biotech company using AI, machine learning, and robotic labs to accelerate drug discovery. It's a "tech-bio" company. This chart shows the average employee value in the sector. It helps assess the market premium placed on their high-tech R&D platform per scientist/engineer.
%20by%20market%20segment%20-%20AI&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-AI&v=1772449011931 "Market capitalization per employee (in thousands of dollars) by market segment - AI")
Market capitalization per employee (in thousands of dollars) for the overall market
Recursion Pharmaceuticals uses artificial intelligence to discover new drugs. This chart shows the average market cap per employee, dramatically demonstrating the enormous value the market places on companies at the intersection of biotech and cutting-edge AI.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772449011935 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Recursion Pharmaceuticals (RXRX)
Recursion Pharmaceuticals uses AI and machine learning to discover new drugs. It's a platform that combines IT and biotech. The company is in the R&D stage. This chart shows the loss per employee. It reflects the massive investment in a unique team of biologists, chemists, and data scientists.
%20Chart%20Recursion%20Pharmaceuticals%20(RXRX)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Recursion-Pharmaceuticals-RXRX&v=1772449011942 "Company Profit Per Employee (in thousands of dollars) Chart Recursion Pharmaceuticals (RXRX)")
Profit per employee (in thousands of dollars) in the market segment - AI
Recursion (RXRX) is a "biotech" company using AI to "discover" drugs. This chart shows the benchmark for "AI" (Biotech). The average profit per employee in this sector is *negative*. The benchmark reflects the "burn" of cash. The entire sector is an R&D race, spending billions on AI engineers and scientists in hopes of a future breakthrough.
%20in%20the%20market%20segment%20-%20AI&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-AI&v=1772449011945 "Chart of profit per employee (in thousands of dollars) in the market segment - AI")
Profit per employee (in thousands of dollars) for the market as a whole
Recursion Pharmaceuticals is a biotech company using AI, robotics, and machine learning to discover new drugs. It's called "techbio." There's no profit. This chart shows the cost of their high-tech R&D platform per employee (scientist, engineer). This is a "burn rate" on steroids, where investments are directed toward the AI platform to accelerate R&D.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772449011953 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Recursion Pharmaceuticals (RXRX)
Recursion Pharmaceuticals uses artificial intelligence to accelerate drug discovery. This chart highlights the potential of this revolutionary business model. It illustrates how AI can boost R&D productivity, enabling a small team of scientists and engineers to create valuable assets for the pharmaceutical industry.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Recursion-Pharmaceuticals-RXRX&v=1772449011960 "Sales chart per company employee Recursion Pharmaceuticals (RXRX)")
Sales per employee in the market segment - AI
Recursion Pharmaceuticals uses artificial intelligence and automated labs to accelerate the drug discovery process. This is an R&D platform. This chart shows the average revenue per employee in the segment. For Recursion, which is in the R&D stage, it serves as a benchmark, setting the productivity bar for commercially successful biotech companies.
Sales per employee for the market as a whole
Recursion Pharmaceuticals uses artificial intelligence and robotics to accelerate drug discovery. It's an R&D platform. This metric (revenue per employee) is not yet relevant, as revenue is incidental (partnerships). The real value lies in the ability of their AI platform and team of scientists to discover drugs more effectively than traditional methods.
Short shares by company, segment and market as a whole
Shares shorted by company Recursion Pharmaceuticals (RXRX)
Recursion Pharmaceuticals uses AI and machine learning to accelerate drug discovery. It's one of the most hyped topics in biotech. However, the technology has yet to prove its effectiveness in practice. This chart shows the volume of bearish bets, believing that this is simply a "fashionable" AI technology, incapable of actually creating successful drugs.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Recursion-Pharmaceuticals-RXRX&v=1772449011986 "Short Shares Chart for the Company Recursion Pharmaceuticals (RXRX)")
Shares shorted by market segment - AI
Recursion Pharmaceuticals uses artificial intelligence and robotic labs to accelerate drug discovery by analyzing cell images. It's a bet on "tech-bio." This chart shows the overall bearish bets across the entire AI biotech sector. If it's rising, it means investors generally doubt AI can quickly and cost-effectively create approved drugs.
Shares shorted by the overall market
Recursion (RXRX) is a biotech company using AI to discover drugs. This indicator (`Short_All`) is a mirror of market fear. When it rises, investors panic and dump "story stocks" (AI + biotech). This pessimism, visible on the chart, deprives RXRX of access to the capital needed for R&D.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Recursion Pharmaceuticals (RXRX)
Recursion uses AI to accelerate drug discovery. It combines two hot topics: biotech and AI. The chart shows the level of excitement or disillusionment surrounding this breakthrough technology. It helps investors identify when stocks are overhyped (overbought) due to AI promise or oversold due to a long R&D cycle, reflecting the extremes of market sentiment.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Recursion-Pharmaceuticals-RXRX&v=1772449011999 "RSI 14 indicator chart for the company's stock Recursion Pharmaceuticals (RXRX)")
RSI 14 Market Segment - AI
Recursion Pharmaceuticals is a next-generation biotech company. They use artificial intelligence, machine learning, and robotic labs to rapidly discover new drugs by analyzing cellular data. This chart reflects the overall sentiment in the AI and biotech sectors. It helps assess whether the hype surrounding AI is overheated.
RSI 14 for the overall market
Recursion Pharmaceuticals (RXRX) uses AI to discover drugs. This chart is an indicator of hype and capital availability. In the euphoria, investors are ready to fund the "future" (AI + biotech). In a panic, they flee unprofitable R&D projects, and the cash spigot for Recursion, which is burning through hundreds of millions, could be shut off.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast RXRX (Recursion Pharmaceuticals)
Recursion Pharmaceuticals is a "TechBio" company that uses AI, robotics, and machine learning to map biological processes and accelerate drug discovery. This chart shows the average price target analysts are predicting for its innovative R&D platform.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-RXRX-Recursion-Pharmaceuticals&v=1772449012008 "A chart showing analyst consensus forecasts for the expected stock price. RXRX (Recursion Pharmaceuticals)")
The difference between the consensus estimate and the actual stock price RXRX (Recursion Pharmaceuticals)
Recursion (RXRX) is a biotech company using AI and robotic labs to radically accelerate drug discovery. This chart is a barometer of faith in their AI platform. It measures the gap between the price and the consensus target, reflecting the enormous potential analysts see in their AI-first R&D model.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-RXRX-Recursion-Pharmaceuticals&v=1772449012012 "A chart showing the difference between the consensus forecast and the actual stock price. RXRX (Recursion Pharmaceuticals)")
Analyst consensus forecast for stock prices by market segment - AI
Recursion Pharmaceuticals, a "TechBio" company that uses artificial intelligence and automated experiments to accelerate drug discovery, is a company that uses artificial intelligence and automated experiments to accelerate drug discovery. This chart shows analysts' overall expectations for the AI sector. It reflects whether experts believe AI can truly reduce the time and cost of drug development.
Analysts' consensus forecast for the overall market share price
Recursion Pharmaceuticals (RXRX) is an AI-based biotech company. They use AI and robotics to accelerate drug discovery. It's a two-pronged bet: on AI and on biotech. This chart of overall market sentiment is critical. Optimism = investors are willing to fund venture capital projects in hot sectors. Pessimism = risk aversion, and these R&D companies suffer.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Recursion Pharmaceuticals
Recursion Pharmaceuticals (RXRX) is a next-generation biotech company. They use AI, machine learning, and robotic labs to commercialize drug discovery. This chart is a valuation of their high-tech platform. It reflects the market's confidence in their AI-first approach and their ability to generate drug candidates faster than traditional pharma.
AKIMA Market Segment Index - AI
Recursion (RXRX) is a technology leader in AI pharma; the company uses its platform (robots, microscopes, AI) to create massive biological maps (atlases) for drug discovery. This summary metric evaluates R&D. The graph shows the average value for the segment. This is a benchmark: how does Recursion's futuristic (AI) R&D platform differentiate it from the average pharma company?
The AKIM Index for the overall market
Recursion is a biotech company using machine learning and automation (TechBio) to discover new drugs at industrial scale. This chart, which reflects the market average, is the backdrop. It helps assess how this story at the intersection of biology and AI fits in with overall macroeconomic trends and the hype surrounding technology.
